<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27362" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mycoplasma Pneumonia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abdulhadi</surname>
            <given-names>Basma</given-names>
          </name>
          <aff>Einstein Healthcare Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kiel</surname>
            <given-names>John</given-names>
          </name>
          <aff>University of South Florida Morsani College of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Basma Abdulhadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Kiel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27362.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p><italic toggle="yes">Mycoplasma pneumonia</italic> is a bacteria that can infect humans. It usually causes upper respiratory tract infections but can also cause pneumonia, and it is one of the most common causes of atypical pneumonia in the United States. Many extrapulmonary infections have been attributed to <italic toggle="yes">M pneumoniae</italic> infections. However, a causal link is yet to be established. This activity reviews the pathophysiology and presentation of mycoplasma pneumonia and highlights the interprofessional team's role in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of<italic toggle="yes"> Mycoplasma pneumonia</italic>.</p></list-item><list-item><p>Review the examination process for a patient with suspected <italic toggle="yes">Mycoplasma pneumonia</italic>.</p></list-item><list-item><p>Outline the management options available for <italic toggle="yes">Mycoplasma pneumonia</italic>.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and outcomes in patients with <italic toggle="yes">Mycoplasma pneumonia.</italic></p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27362&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27362">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27362.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Mycoplasma&#x000a0;pneumonia </italic>is a bacteria that&#x000a0;can infect humans. It usually causes upper respiratory tract infections but can also cause pneumonia, and it&#x000a0;is one of the most common causes of atypical pneumonia in the United States.&#x000a0;Many extrapulmonary infections have been attributed to <italic toggle="yes">M pneumoniae</italic> infections. However, a causal link is yet to be established.<xref ref-type="bibr" rid="article-27362.r1">[1]</xref><xref ref-type="bibr" rid="article-27362.r2">[2]</xref><xref ref-type="bibr" rid="article-27362.r3">[3]</xref>&#x000a0;Reimann first described this condition after observing a series of 7 patients with marked constitutional symptoms and termed it 'primary atypical pneumonia.'</p>
      </sec>
      <sec id="article-27362.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Mycoplasma</italic>&#x000a0;species&#x000a0;are the smallest living organisms that can survive alone&#x000a0;in nature. There are over 120 <italic toggle="yes">Mycoplasma</italic> species; only 13 have been isolated from humans, and only four are known to cause disease in humans. <italic toggle="yes">M pneumoniae</italic>&#x000a0;is the pathogen most commonly associated with disease in humans. It is a short rod with no cell wall; therefore, it is not visible on the Gram stain. It can be isolated on media supplemented with serum. However, it is fastidious, and isolation is not usually performed in clinical laboratories.<xref ref-type="bibr" rid="article-27362.r4">[4]</xref>&#x000a0;It requires special culture media and also takes a long time for growth. Due to these reasons, it is not routinely cultured. It is excreted from the respiratory tract after many weeks of acute infection; therefore, isolation of the organism is not specific to acute infection at that particular time.</p>
      </sec>
      <sec id="article-27362.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">M pneumoniae</italic>&#x000a0;is now considered a common cause of community-acquired pneumonia and is transmitted from person to person via respiratory droplets during close contact. It has an incubation period that ranges between 2 to 3 weeks. Like most respiratory pathogens, infection usually occurs during the winter months but can happen year-round. Estimates show that around 1% of the population of the United States is infected annually. Incidence may be much higher since infection can be subclinical or cause milder disease that does not require hospitalization. Outbreaks of mycoplasma infection occur in military recruits, hospitals, nursing homes, and other long-term care facilities.<xref ref-type="bibr" rid="article-27362.r5">[5]</xref><xref ref-type="bibr" rid="article-27362.r4">[4]</xref>&#x000a0;Only 5&#x000a0;to 10% of people infected with mycoplasma&#x000a0;develop pneumonia. It causes upper and lower respiratory tract infections in all age groups.</p>
      </sec>
      <sec id="article-27362.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">M pneumoniae</italic>&#x000a0;has&#x000a0;adherence proteins that can attach to epithelial membranes, particularly the respiratory tract epithelium.&#x000a0;Once attached,&#x000a0;<italic toggle="yes">M pneumoniae</italic>&#x000a0;produces&#x000a0;hydrogen peroxide and superoxide, causing injury to epithelial cells and their associated cilia.&#x000a0;Antibodies produced against <italic toggle="yes">M pneumoniae</italic> may act as autoantibodies since they crossreact with human brain cells and red blood cells. The pathogenesis of <italic toggle="yes">M pneumoniae</italic> includes the activation of inflammatory cytokines.</p>
        <p><italic toggle="yes">M pneumoniae</italic> has a gliding movement and specific tip organelles that help in burrowing between cilia in the respiratory epithelium, leading to the sloughing of the respiratory epithelial cells. The prolonged refractory cough is considered to be due to inhibition of the ciliary movement. <italic toggle="yes">M pneumoniae</italic> causes extrapulmonary illnesses and respiratory tract infections, including immune thrombocytopenic purpura, acute hepatitis, autoimmune hemolytic anemia, arthritis, and transverse myelitis.</p>
      </sec>
      <sec id="article-27362.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Many <italic toggle="yes">M pneumoniae</italic> infections&#x000a0;are asymptomatic. Patient&#x000a0;symptoms are typically more significant than&#x000a0;objective findings on physical exams. Disease onset is gradual, and patients can initially complain of headaches, malaise, and low-grade fever. A nagging cough is usually the most prominent respiratory feature. Chest soreness from coughing is common.&#x000a0;Wheezing can also occur. Other respiratory symptoms include pharyngitis, rhinorrhea, and ear pain. Pleural effusion occurs in 15% to 20% of patients who develop pneumonia and may predict increased morbidity and mortality. &#x000a0;Most cases of pneumonia are mild and self-limited. However, a more fulminant course can occur. Extrapulmonary features may help suggest the diagnosis and include hemolysis, skin rash, joint pain, gastrointestinal symptoms, and heart disease. These occur in less than 5% to 10% of patients. Hemolysis occurs due to IgM antibodies producing a cold agglutinin reaction. Cardiac involvement includes conduction abnormalities on electrocardiogram, congestive heart failure, and chest pain.</p>
        <p>Physical examination findings are often minimal. Chest auscultation can be normal even if pneumonia is present. Scattered rales and wheezes can present later in the course of the disease. Sinus tenderness and mild erythema of the posterior pharynx may also be found on physical examination. A mild&#x000a0;erythematous maculopapular or vesicular rash may also be found. Bullous myringitis, the presence of vesicles or bulls on the tympanic membrane, can be seen in some cases.</p>
      </sec>
      <sec id="article-27362.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There are no specific clinical or radiological findings of mycoplasma pneumonia that can differentiate it from other causes of atypical pneumonia. However, patients tend to&#x000a0;have a more gradual onset of disease, more multisystem involvement, and a normal&#x000a0;white blood cell count. Patients usually present in an outpatient setting, and microbial diagnosis is not usually performed for outpatients with community-acquired pneumonia since empiric treatment is usually successful. When available, PCR can be done rapidly and is the test of choice. Testing for cold agglutinins can sometimes support a clinical diagnosis when a rapid diagnosis must be made.&#x000a0;<italic toggle="yes">M pneumoniae</italic>&#x000a0;lacks a cell wall and is fastidious; therefore, Gram stain and cultures are not useful for the diagnosis of these organisms.<xref ref-type="bibr" rid="article-27362.r6">[6]</xref><xref ref-type="bibr" rid="article-27362.r7">[7]</xref>&#x000a0;Mycoplasma pneumoniae is difficult to culture; a special culture media and 7&#x000a0;to 21 days must culture it. Serologic tests like complement fixation, enzyme-linked immunoassay, immunochromatography, and hemagglutination have acceptable sensitivity and specificity. Those serologic tests that show a four-fold greater increase or decrease in paired sera titers or a single tire of more than 1: 32 are diagnostic of Mycoplasma pneumoniae.</p>
        <p>Hemolysis is found in most patients with pneumonia and causes a positive Coomb test and an elevated reticulocyte count. Cold agglutinin titers are elevated in more than 50% of patients with mycoplasma disease. However, this is not specific to mycoplasma infections and can be found in patients with viral pneumonia or infectious mononucleosis due to the Epstein-Barr virus or cytomegalovirus.&#x000a0;White blood cell count is normal in 75% to 90% of cases.&#x000a0;The most common chest x-ray findings are a reticulonodular pattern&#x000a0;or&#x000a0;patchy areas of consolidation; these can be unilateral or bilateral and are more prominent in the lower lobes.<xref ref-type="bibr" rid="article-27362.r8">[8]</xref><xref ref-type="bibr" rid="article-27362.r9">[9]</xref>&#x000a0;Eosinophil cationic protein is elevated in patients with mycoplasma infection and asthma. It is believed that&#x000a0;this protein damages the epithelium in the airways and induces hypersensitivity of the bronchial smooth muscle. However, more studies are required before its use as a diagnostic marker becomes universal.<xref ref-type="bibr" rid="article-27362.r10">[10]</xref></p>
      </sec>
      <sec id="article-27362.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Gradual onset of symptoms combined with extrapulmonary involvement and a normal white blood cel count points to atypical pneumonia. Most patients with <italic toggle="yes">M pneumoniae</italic> pneumonia present in outpatient settings, and treatment is often with empiric antibiotics for atypical pneumonia. Note that many patients may undergo a period of symptomatic management before seeking medical attention and/or receiving antibiotic treatment.</p>
        <p>Treatment of <italic toggle="yes">M pneumoniae</italic> includes macrolides, doxycycline, or fluoroquinolones. Azithromycin is the most frequently used antibiotic and is usually prescribed for 5 days (500 mg for the first dose, followed by 250 mg daily for 4 days). Patients receiving doxycycline or fluoroquinolones should be given 7 to 14 days of treatment.<xref ref-type="bibr" rid="article-27362.r11">[11]</xref><xref ref-type="bibr" rid="article-27362.r12">[12]</xref>&#x000a0;Macrolide resistance continues to emerge, so if a patient is not responding to macrolides, other antibiotics can be given. Routine antibiotic prophylaxis is not required for the exposed contacts except for those prone to serious mycoplasmal infection, like patients with sickle cell disease or antibody deficiency. For prophylaxis, doxycycline or macrolides are used.</p>
      </sec>
      <sec id="article-27362.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Diagnostic Considerations</bold>
</p>
        <p><italic toggle="yes">M pneumoniae</italic> is a prevalent cause of community-acquired pneumonia in healthy individuals younger than 40. Large outbreaks are known to occur in the late summer months and early fall. The infection is also more common in populations that live in close quarters like prisoners and military personnel. Unlike other viral pneumonia, the incubation period for mycoplasma is 14&#x000a0;to 21 days. The key feature of the diagnosis is the absence of a wet cough. Other diagnoses that can be confused with mycoplasma pneumonia include&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aspiration pneumonitis and pneumonia</p>
          </list-item>
          <list-item>
            <p>Bacterial pneumonia</p>
          </list-item>
          <list-item>
            <p>Chlamydia pneumoniae</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Coxiella burnetii</italic> infection</p>
          </list-item>
          <list-item>
            <p>Empyema</p>
          </list-item>
          <list-item>
            <p>Legionella pneumophila</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
          <list-item>
            <p>Pediatric pneumonia</p>
          </list-item>
          <list-item>
            <p>Q fever</p>
          </list-item>
          <list-item>
            <p>Viral pneumonia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27362.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In most patients who receive prompt treatment, the prognosis is excellent, and patients are expected to make a full recovery. The symptoms and signs of pneumonia usually resolve within a few days without any complications. However, in young children, the infection can be associated with severe pneumonia, and in patients with sickle cell anemia, it may be associated with acute chest syndrome. The immunity after an <italic toggle="yes">M pneumoniae</italic> infection is short-lived.</p>
      </sec>
      <sec id="article-27362.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Even though mycoplasma pneumonia in most people is a benign infection, it can lead to several complications, especially in children and the elderly. The list of complications includes&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>ARDS</p>
          </list-item>
          <list-item>
            <p>Bronchiolitis obliterans</p>
          </list-item>
          <list-item>
            <p>Lobar consolidation</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
          <list-item>
            <p>Necrotizing pneumonitis</p>
          </list-item>
          <list-item>
            <p>Pleural effusion (15% to 20%), empyema (rare)</p>
          </list-item>
          <list-item>
            <p>Respiratory failure</p>
          </list-item>
        </list>
        <p>
<bold>Extrapulmonary Complications</bold>
</p>
        <p>Mycoplasma can also be associated with severe extrapulmonary complications. These complications may be due to the organism itself; they may be triggered by the resulting immunological response to the bacteria. The list of extrapulmonary complications includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Myocardium problems: Conduction abnormalities, heart blocks, or rhythm disturbances. Both pericarditis and congestive heart failure have been reported in young people.</p>
          </list-item>
          <list-item>
            <p>The central nervous system: Rare but can include encephalitis, transverse myelitis, aseptic meningitis, and cerebellar ataxia. These central nervous system complications are more common in children.</p>
          </list-item>
          <list-item>
            <p>Hematologic problems: Hemolytic anemia due to cross-reactivity of antibodies to <italic toggle="yes">M Pneumoniae</italic> antigens to red blood cells. The hemolysis is mild.</p>
          </list-item>
          <list-item>
            <p>Dermatology: <italic toggle="yes">M Pneumoniae</italic> infection may be associated with urticaria, erythema nodosum, or Steven Johnson syndrome. The skin lesions are seen in about one-third of patients.</p>
          </list-item>
          <list-item>
            <p>Musculoskeletal problems include myalgia and arthralgia. Septic arthritis is very rare. Rare cases of rhabdomyolysis have been reported.</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal dysfunctions include pancreatitis or hepatitis and are linked to the circulating immunoglobulin M antibodies.</p>
          </list-item>
          <list-item>
            <p>Ophthalmologic problems include conjunctivitis, optic papillitis, anterior uveitis, and cranial neuropathies.</p>
          </list-item>
          <list-item>
            <p>Kidney problems are rare and may result in glomerulonephritis due to immune complex precipitation in the glomeruli.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27362.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need counsel regarding infection prevention. This includes information regarding getting the pneumococcal vaccine,&#x000a0;as well as the influenza vaccine, which in addition to helping prevent influenza, can thwart possible complications, such as pneumonia. If the patient smokes, they should receive strong counsel and support to stop, as it can preclude pneumonia and other health concerns. Addressing any underlying conditions (eg, asthma, diabetes, congestive heart failure) can also help prevent pneumonia.</p>
      </sec>
      <sec id="article-27362.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>As for the prevention of infection, there are currently&#x000a0;no vaccines for<italic toggle="yes">&#x000a0;M pneumoniae</italic>. Several studies looked at the efficacy of azithromycin prophylaxis in military training facilities and other closed settings. However, there are still no recommendations for these practices. Patients hospitalized with M pneumoniae infection should be placed on droplet precautions for the full duration of their illness.</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">M pneumoniae</italic>&#x000a0;is a common cause of pneumonia.</p>
          </list-item>
          <list-item>
            <p>Prodromal symptoms include headache and fever, and patients subsequently develop a dry cough.</p>
          </list-item>
          <list-item>
            <p>It is frequently subclinical and thus underdiagnosed due to a lack of symptoms or specific diagnostic criteria.</p>
          </list-item>
          <list-item>
            <p>Chest radiographs often do not show an infiltrate.</p>
          </list-item>
          <list-item>
            <p>Management is with antibiotics, generally azithromycin.</p>
          </list-item>
          <list-item>
            <p>Children, older adults, and individuals with sickle cell disease are at risk of complications.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27362.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Mycoplasma pneumonia is often encountered by the primary care provider, nurse practitioner, emergency department physician, and internist. As such, it requires the efforts of an interprofessional team that includes clinicians, specialists, nurses, and pharmacists. Cross-disciplinary communication within this interprofessional arrangement will result in better patient outcomes. &#x000a0;Because there are no rapid tests to detect this organism, most patients are treated empirically. The pneumonia is benign, and most patients have an uneventful recovery. However, some patients may develop a parapneumonic effusion, otitis media, lung abscess, or empyema. These patients are best referred to as the appropriate specialty for further management. In immunocompromised and transplant individuals, an infectious disease consult should be made.<xref ref-type="bibr" rid="article-27362.r13">[13]</xref></p>
      </sec>
      <sec id="article-27362.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27362&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27362">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/mycoplasma-pneumonia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27362">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27362/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27362">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27362.s16">
        <title>References</title>
        <ref id="article-27362.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cai</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>XG</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of mycoplasma pneumoniae by loop-mediated isothermal amplification: systematic review and meta-analysis.</article-title>
            <source>BMC Infect Dis</source>
            <year>2019</year>
            <month>Feb</month>
            <day>19</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>173</fpage>
            <pub-id pub-id-type="pmid">30782134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Lanao</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Chakraborty</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Pearson-Shaver</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <chapter-title>Mycoplasma Infections</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">30725612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>A concise review of vaccines against Mycoplasma hyopneumoniae.</article-title>
            <source>Res Vet Sci</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>123</volume>
            <fpage>144</fpage>
            <page-range>144-152</page-range>
            <pub-id pub-id-type="pmid">30665029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological relationship between <italic>Mycoplasma pneumoniae</italic> pneumonia and recurrent wheezing episode in children: an observational study at a single hospital in Korea.</article-title>
            <source>BMJ Open</source>
            <year>2019</year>
            <month>Apr</month>
            <day>11</day>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>e026461</fpage>
            <pub-id pub-id-type="pmid">30975681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>AKC</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>AHC</given-names>
              </name>
              <name>
                <surname>Hon</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Community-Acquired Pneumonia in Children.</article-title>
            <source>Recent Pat Inflamm Allergy Drug Discov</source>
            <year>2018</year>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-144</page-range>
            <pub-id pub-id-type="pmid">29932038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016.</article-title>
            <source>BMC Infect Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <day>17</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>335</fpage>
            <pub-id pub-id-type="pmid">30016939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bajantri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Venkatram</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diaz-Fuentes</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycoplasma pneumoniae</italic>: A Potentially Severe Infection.</article-title>
            <source>J Clin Med Res</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>535</fpage>
            <page-range>535-544</page-range>
            <pub-id pub-id-type="pmid">29904437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Draenert</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seybold</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bogner</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Atypical pneumonia - important facts for the general practitioner].</article-title>
            <source>MMW Fortschr Med</source>
            <year>2018</year>
            <month>May</month>
            <volume>160</volume>
            <issue>10</issue>
            <fpage>41</fpage>
            <page-range>41-44</page-range>
            <pub-id pub-id-type="pmid">29855903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycoplasma pneumoniae</italic>: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.</article-title>
            <source>Indian J Med Res</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>147</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-31</page-range>
            <pub-id pub-id-type="pmid">29749357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>XD</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Situation of Community-acquired Pneumonia in China: A Systematic Review.</article-title>
            <source>J Transl Int Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-31</page-range>
            <pub-id pub-id-type="pmid">29607301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saraya</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycoplasma pneumoniae</italic> infection: Basics.</article-title>
            <source>J Gen Fam Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>118</fpage>
            <page-range>118-125</page-range>
            <pub-id pub-id-type="pmid">29264006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Melnick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hackett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, microbiology, and treatment patterns of pediatric patients hospitalized with pneumonia at two hospitals in China: a patient chart review study.</article-title>
            <source>Ther Clin Risk Manag</source>
            <year>2018</year>
            <volume>14</volume>
            <fpage>501</fpage>
            <page-range>501-510</page-range>
            <pub-id pub-id-type="pmid">29559786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27362.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>LY</given-names>
              </name>
            </person-group>
            <article-title>Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter?</article-title>
            <source>J Microbiol Immunol Infect</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>329</fpage>
            <page-range>329-335</page-range>
            <pub-id pub-id-type="pmid">30341022</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
